Related Experiment Videos
Scope and impact of allergic rhinitis
1Division of Pulmonary and Critical Care Medicine, Temple University Hospital in Philadelphia, PA 19140, USA. gdalonzo@nimbus.temple.edu
The Journal of the American Osteopathic Association
|July 2, 2002
Summary
Allergic rhinitis affects millions, causing significant health and economic burdens. Allergy vaccine therapy offers a potential treatment for severe cases refractory to other methods.
Area of Science:
- Immunology
- Allergology
- Clinical Medicine
Background:
- Allergic rhinitis impacts 40 million Americans, causing substantial healthcare costs and reduced quality of life.
- The condition's complex pathophysiology involves immune cells and inflammatory mediators.
- Allergen avoidance is difficult, necessitating pharmacotherapy for most patients.
Purpose of the Study:
- To review the pathophysiology and management of allergic rhinitis.
- To highlight the role of allergy vaccine therapy in refractory cases.
Main Methods:
- Literature review of allergic rhinitis pathophysiology and treatment options.
- Analysis of clinical management principles and therapeutic modalities.
Main Results:
- Allergic rhinitis presents a significant health burden with complex underlying mechanisms.
- Pharmacotherapy is a common treatment, but allergy vaccine therapy is a viable option for specific patient groups.
Conclusions:
- Allergy vaccine therapy is an important consideration for patients with allergic rhinitis unresponsive to conventional treatments.
- Effective management requires understanding the disease's complexity and individual patient needs.